Scarica l'app Stockscreener
142.24
1.78%
+2.49
Pre-mercato:
149.75
7.51
+5.28%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DVA Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$139.75
Aprire:
$141.37
Volume 24 ore:
1.86M
Capitalizzazione di mercato:
$12.47B
Reddito:
$12.14B
Utile/perdita netta:
$691.54M
Rapporto P/E:
28.28
EPS:
5.03
Flusso di cassa netto:
$1.49B
1 W Prestazione:
+7.13%
1M Prestazione:
+5.33%
6M Prestazione:
+82.80%
1 anno Prestazione:
+61.01%
Intervallo 1D:
$139.72
$143.23
Portata 52W:
$71.51
$143.23
DaVita Inc Stock (DVA) Company Profile
Nome
DaVita Inc
Settore
Industria
Telefono
303-405-2100
Indirizzo
2000 16th Street, Denver, CO
DaVita Inc Stock (DVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-08-07 | Aggiornamento | UBS | Neutral → Buy |
| 2022-11-01 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Downgrade | UBS | Buy → Neutral |
| 2022-08-19 | Ripresa | UBS | Buy |
| 2022-06-21 | Reiterato | BofA Securities | Underperform |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-08-12 | Downgrade | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-01-24 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-11-07 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Aggiornamento | UBS | Sell → Neutral |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2018-12-14 | Iniziato | Barclays | Overweight |
| 2018-11-28 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Iniziato | UBS | Sell |
| 2018-11-08 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2017-12-07 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Downgrade | Jefferies | Buy → Hold |
| 2016-12-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mostra tutto
DaVita Inc Borsa (DVA) Ultime notizie
DaVita (DVA) Q1 2024 Earnings Call Transcript
The Motley Fool
DaVita HealthCare (DVA) Surpasses Q1 Earnings and Revenue Estimates
Zacks Investment Research
Strength in Kidney Care Likely to Aid DaVita's (DVA) Q1 Earnings
Zacks Investment Research
What's in Store for These 5 Medical Device Stocks in Q1 Earnings?
Zacks Investment Research
Warren Buffett's 3 Best-Performing Stocks So Far in 2024: Are They Buys Now?
The Motley Fool
DaVita HealthCare (DVA) Increases Despite Market Slip: Here's What You Need to Know
Zacks Investment Research
DaVita Inc Azioni (DVA) Dati Finanziari
DaVita Inc (DVA) Reddito 2024
DVA ha riportato un ricavo (TTM) di $12.14 miliardi per il trimestre terminato il 2023-12-31, un +4.57% salita anno su anno.
DaVita Inc (DVA) Reddito netto 2024
DVA l'utile netto (TTM) è stato di $691.53 milioni per il trimestre terminato il 2023-12-31, un +23.40% aumento anno su anno.
DaVita Inc (DVA) Flusso di cassa 2024
DVA ha registrato un flusso di cassa disponibile (TTM) di $1.49 miliardi per il trimestre conclusosi con 2023-12-31, un +55.13% aumento anno su anno.
DaVita Inc (DVA) Utile per azione 2024
L'utile per azione (TTM) di DVA è stato pari a $7.40 per il trimestre terminato il 2023-12-31, un +28.03% crescita anno su anno.
DaVita Inc Azioni (DVA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| STAFFIERI MICHAEL DAVID | Chief Operating Officer, DKC |
Mar 13 '24 |
Option Exercise |
52.41 |
50,000 |
2,620,500 |
102,748 |
| Rodriguez Javier | Chief Executive Officer |
Mar 06 '24 |
Option Exercise |
67.80 |
750,000 |
50,850,000 |
1,244,480 |
| ACKERMAN JOEL | CFO and Treasuer |
Mar 06 '24 |
Option Exercise |
52.41 |
55,000 |
2,882,550 |
195,360 |
| STAFFIERI MICHAEL DAVID | Chief Operating Officer, DKC |
Mar 06 '24 |
Option Exercise |
52.41 |
50,000 |
2,620,500 |
87,687 |
| Rodriguez Javier | Chief Executive Officer |
Feb 28 '24 |
Option Exercise |
67.80 |
50,000 |
3,390,000 |
531,300 |
| Rodriguez Javier | Chief Executive Officer |
Feb 27 '24 |
Sale |
126.87 |
7,397 |
938,467 |
481,300 |
| Rodriguez Javier | Chief Executive Officer |
Feb 26 '24 |
Option Exercise |
67.80 |
450,000 |
30,510,000 |
889,002 |
| Rodriguez Javier | Chief Executive Officer |
Feb 26 '24 |
Sale |
126.11 |
67,603 |
8,525,130 |
488,697 |
| STAFFIERI MICHAEL DAVID | Chief Operating Officer, DKC |
Feb 21 '24 |
Option Exercise |
52.41 |
100,000 |
5,241,000 |
137,687 |
| ACKERMAN JOEL | CFO and Treasuer |
Feb 21 '24 |
Option Exercise |
52.41 |
55,000 |
2,882,550 |
178,726 |
2.07%
0.18%
Capitalizzazione:
|
Volume (24 ore):